360
Participants
Start Date
March 1, 2013
Primary Completion Date
November 4, 2015
Study Completion Date
November 4, 2015
SPIL1033
5 mcg twice daily for the first 4 weeks and 10 mcg twice daily for the remaining 20 weeks. To be self-administered twice daily.
Placebo
5 mcg twice daily for the first 4 weeks and 10 mcg twice daily for the remaining 20 weeks. To be self-administered twice daily.
SPIL Site 18, Madurai
SPIL Site 22, Hyderabad
SPIL Site 25, Hyderabad
SPIL Site 26, Hyderabad
SPIL Site 23, Visakhapatnam
SPIL Site 1, Ahmedabad
SPIL Site 2, Ahmedabad
SPIL Site 3, Ahmedabad
SPIL Site 5, Rajkot
SPIL Site 6, Surat
SPIL Site 7, Surat
SPIL Site 8, Surat
SPIL Site 9, Surat
SPIL Site 10, Vadodara
SPIL Site 19, Bangalore
SPIL Site 30, Bangalore
SPIL Site 31, Bangalore
SPIL Site 33, Bangalore
SPIL Site 29, Manipal
SPIL Site 35, Indore
SPIL Site 21, Nagpur
SPIL Site 24, Nagpur
SPIL Site 32, Nashik
SPIL Site 11, Pune
SPIL Site 12, Pune
SPIL Site 13, Bhubaneshwar
SPIL Site 14, Jaipur
SPIL Site 15, Jaipur
SPIL Site 16, Chennai
SPIL Site 17, Coimbatore
SPIL Site 20, Coimbatore
SPIL Site 34, Vellore
SPIL Site 27, Lucknow
SPIL Site 28, Lucknow
Sun Pharmaceutical Industries Limited
INDUSTRY